Detalhe da pesquisa
1.
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
N Engl J Med
; 388(3): 228-239, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652354
2.
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer.
Br J Cancer
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834744
3.
Phase II trial of niraparib for BRCA-mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B.
Future Oncol
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38629456
4.
Evaluation of the risk factors for the failure of a single prophylactic dose of anticholinergic drugs for irinotecan-induced cholinergic symptoms.
Int J Clin Pharmacol Ther
; 62(5): 213-221, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431832
5.
English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(6): 647-680, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609732
6.
Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers.
Cancer Sci
; 114(8): 3385-3395, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208840
7.
Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment.
Jpn J Clin Oncol
; 53(9): 764-773, 2023 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37325968
8.
Risk factor analysis for anti-epidermal growth factor receptor monoclonal antibody-induced skin toxicities in real-world metastatic colorectal cancer treatment.
Support Care Cancer
; 31(8): 504, 2023 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37528282
9.
Evaluation of the additional prophylactic effect of topical steroid ointment to systemic minocycline against anti-epidermal growth factor antibody-induced skin toxicities in metastatic colorectal cancer treatment.
Support Care Cancer
; 32(1): 8, 2023 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055053
10.
Severe hypertension development significantly improves progression-free survival in regorafenib treatment for metastatic colorectal cancer.
Int J Clin Oncol
; 28(9): 1183-1190, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322220
11.
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA
; 329(15): 1271-1282, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071094
12.
Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1.
Cancer Sci
; 113(3): 1018-1027, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34962019
13.
Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201).
Oncologist
; 27(5): 340-e374, 2022 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303078
14.
Phase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer: HGCSG1603.
Oncologist
; 27(8): e642-e649, 2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579511
15.
An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumors.
Invest New Drugs
; 40(5): 1011-1020, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932386
16.
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study.
BMC Cancer
; 22(1): 1322, 2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36526992
17.
Long-term adjuvant therapy for high-risk gastrointestinal stromal tumors in the real world.
Gastric Cancer
; 25(5): 956-965, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672526
18.
Multicenter phase II trial of trastuzumab deruxtecan for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial.
Future Oncol
; 18(19): 2351-2360, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35510484
19.
Risk factor analysis for regorafenib-induced severe hypertension in metastatic colorectal cancer treatment.
Support Care Cancer
; 30(12): 10203-10211, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36217043
20.
Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer.
Support Care Cancer
; 30(6): 5351-5359, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35292848